Tech Funding News· Sofia Chesnokova·· 5 days agoTop DealsAI Score71
Orakl Oncology raises $34M Series A to predict cancer drug trial outcomes with AI
Paris-based Orakl Oncology scoops $34M for AI cancer drug prediction
AI Overview
Paris-based Orakl Oncology raised $34M in a Series A led by Norrsken VC and Singular.
Why it matters
The round and the Sanofi asset deal give a concrete test of whether Orakl's 90% trial-prediction figure holds up outside a preprint.
Source:Tech Funding News · techfundingnews.com
Subscribe to the newsletters
Free, by email. No account needed. Pick one or both.
No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.
Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing